BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25452636)

  • 1. The UGT1 locus is a determinant of prostate cancer recurrence after prostatectomy.
    Laverdière I; Flageole C; Audet-Walsh É; Caron P; Fradet Y; Lacombe L; Lévesque É; Guillemette C
    Endocr Relat Cancer; 2015 Feb; 22(1):77-85. PubMed ID: 25452636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletions of the androgen-metabolizing UGT2B genes have an effect on circulating steroid levels and biochemical recurrence after radical prostatectomy in localized prostate cancer.
    Nadeau G; Bellemare J; Audet-Walsh É; Flageole C; Huang SP; Bao BY; Douville P; Caron P; Fradet Y; Lacombe L; Guillemette C; Lévesque E
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1550-7. PubMed ID: 21733997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association analysis of Wnt pathway genes on prostate-specific antigen recurrence after radical prostatectomy.
    Huang SP; Ting WC; Chen LM; Huang LC; Liu CC; Chen CW; Hsieh CJ; Yang WH; Chang TY; Lee HZ; Bao BY
    Ann Surg Oncol; 2010 Jan; 17(1):312-22. PubMed ID: 19777185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of germline genetic variations in hydroxysteroid (17-beta) dehydrogenases on prostate cancer outcomes after prostatectomy.
    Audet-Walsh É; Bellemare J; Lacombe L; Fradet Y; Fradet V; Douville P; Guillemette C; Lévesque É
    Eur Urol; 2012 Jul; 62(1):88-96. PubMed ID: 22209174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic interaction analysis of TCF7L2 for biochemical recurrence after radical prostatectomy in localized prostate cancer.
    Chen CS; Huang CY; Huang SP; Lin VC; Yu CC; Chang TY; Bao BY
    Int J Med Sci; 2015; 12(3):243-7. PubMed ID: 25678841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.
    Huang SP; Huang LC; Ting WC; Chen LM; Chang TY; Lu TL; Lan YH; Liu CC; Yang WH; Lee HZ; Hsieh CJ; Bao BY
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3068-74. PubMed ID: 19900942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants in the Hippo pathway predict biochemical recurrence after radical prostatectomy for localized prostate cancer.
    Huang CY; Huang SP; Lin VC; Yu CC; Chang TY; Juang SH; Bao BY
    Sci Rep; 2015 Feb; 5():8556. PubMed ID: 25707771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of cyclin D1 polymorphisms on prostate-specific antigen recurrence after radical prostatectomy.
    Yu CC; Lin VC; Huang CY; Liu CC; Wang JS; Wu TT; Pu YS; Huang CH; Huang CN; Huang SP; Bao BY
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S492-9. PubMed ID: 23354566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence.
    Gu C; Li Q; Zhu Y; Qu Y; Zhang G; Wang M; Yang Y; Wang J; Jin L; Wei Q; Ye D
    Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):310-6. PubMed ID: 26238235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic predisposition to early recurrence in clinically localized prostate cancer.
    Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
    BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SRD5A polymorphisms and biochemical failure after radical prostatectomy.
    Audet-Walsh E; Bellemare J; Nadeau G; Lacombe L; Fradet Y; Fradet V; Huang SP; Bao BY; Douville P; Girard H; Guillemette C; Lévesque E
    Eur Urol; 2011 Dec; 60(6):1226-34. PubMed ID: 21715084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer.
    Bañez LL; Sun L; van Leenders GJ; Wheeler TM; Bangma CH; Freedland SJ; Ittmann MM; Lark AL; Madden JF; Hartman A; Weiss G; Castaños-Vélez E
    J Urol; 2010 Jul; 184(1):149-56. PubMed ID: 20478579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in microRNAs and microRNA target sites predict biochemical recurrence after radical prostatectomy in localized prostate cancer.
    Huang SP; Lévesque E; Guillemette C; Yu CC; Huang CY; Lin VC; Chung IC; Chen LC; Laverdière I; Lacombe L; Fradet Y; Chang TY; Lee HZ; Juang SH; Bao BY
    Int J Cancer; 2014 Dec; 135(11):2661-7. PubMed ID: 24740842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single nucleotide polymorphism in ADIPOQ predicts biochemical recurrence after radical prostatectomy in localized prostate cancer.
    Gu C; Qu Y; Zhang G; Sun L; Zhu Y; Ye D
    Oncotarget; 2015 Oct; 6(31):32205-11. PubMed ID: 26320190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomy.
    Huang SP; Huang CY; Wang JS; Liu CC; Pu YS; Yu HJ; Yu CC; Wu TT; Huang CH; Wu WJ; Chou YH; Wu MT
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6632-8. PubMed ID: 18006764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short (≤ 1 mm) positive surgical margin and risk of biochemical recurrence after radical prostatectomy.
    Shikanov S; Marchetti P; Desai V; Razmaria A; Antic T; Al-Ahmadie H; Zagaja G; Eggener S; Brendler C; Shalhav A
    BJU Int; 2013 Apr; 111(4):559-63. PubMed ID: 22759270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common variants in IGF1 pathway genes and clinical outcomes after radical prostatectomy.
    Chang CF; Pao JB; Yu CC; Huang CY; Huang SP; Yang YP; Huang CN; Chang TY; You BJ; Lee HZ; Hour TC; Bao BY
    Ann Surg Oncol; 2013 Jul; 20(7):2446-52. PubMed ID: 23397154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants of the CYP1B1 gene as predictors of biochemical recurrence after radical prostatectomy in localized prostate cancer patients.
    Gu CY; Qin XJ; Qu YY; Zhu Y; Wan FN; Zhang GM; Sun LJ; Zhu Y; Ye DW
    Medicine (Baltimore); 2016 Jul; 95(27):e4066. PubMed ID: 27399092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.
    Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D
    BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of cytokine gene polymorphisms on prostate-specific antigen recurrence in prostate cancer after radical prostatectomy.
    Lin HC; Liu CC; Kang WY; Yu CC; Wu TT; Wang JS; Wu WJ; Huang CH; Wu MT; Huang SP
    Urol Int; 2009; 83(4):463-70. PubMed ID: 19996656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.